NFKB1 and neoplasm: IL-6 and TNF-α are central activators of NF-κB, driving angiogenesis, epithelial–mesenchymal transition, and resistance to apoptosis, while IL-1β has been implicated in promoting immunosuppression and metastatic spread within the tumor microenvironment.